These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15239059)

  • 21. Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation.
    Jaramillo C; de Diego JE; Hamdouchi C; Collins E; Keyser H; Sánchez-Martínez C; del Prado M; Norman B; Brooks HB; Watkins SA; Spencer CD; Dempsey JA; Anderson BD; Campbell RM; Leggett T; Patel B; Schultz RM; Espinosa J; Vieth M; Zhang F; Timm DE
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6095-9. PubMed ID: 15546737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylases.
    Grolla AA; Podestà V; Chini MG; Di Micco S; Vallario A; Genazzani AA; Canonico PL; Bifulco G; Tron GC; Sorba G; Pirali T
    J Med Chem; 2009 May; 52(9):2776-85. PubMed ID: 19344175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and evaluation of octahydropyranopyrrole-based inhibitors of mammalian ribonucleotide reductase.
    Fuertes MJ; Kaur J; Deb P; Cooperman BS; Smith AB
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5146-9. PubMed ID: 16176875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-driven HtL: design and synthesis of novel aminoindazole inhibitors of c-Jun N-terminal kinase activity.
    Stocks MJ; Barber S; Ford R; Leroux F; St-Gallay S; Teague S; Xue Y
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3459-62. PubMed ID: 15950471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel isothiazole inhibitors of the TrkA kinase: structure-activity relationship, computer modeling, optimization, and identification of highly potent antagonists.
    Lippa B; Morris J; Corbett M; Kwan TA; Noe MC; Snow SL; Gant TG; Mangiaracina M; Coffey HA; Foster B; Knauth EA; Wessel MD
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3444-8. PubMed ID: 16632359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fragment-based drug discovery.
    Erlanson DA; McDowell RS; O'Brien T
    J Med Chem; 2004 Jul; 47(14):3463-82. PubMed ID: 15214773
    [No Abstract]   [Full Text] [Related]  

  • 29. Design, synthesis, and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors.
    Yamashita T; Kamata M; Endo S; Yamamoto M; Kakegawa K; Watanabe H; Miwa K; Yamano T; Funata M; Sakamoto J; Tani A; Mol CD; Zou H; Dougan DR; Sang B; Snell G; Fukatsu K
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6314-8. PubMed ID: 21944854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase.
    Hopkins CR; Czekaj M; Kaye SS; Gao Z; Pribish J; Pauls H; Liang G; Sides K; Cramer D; Cairns J; Luo Y; Lim HK; Vaz R; Rebello S; Maignan S; Dupuy A; Mathieu M; Levell J
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2734-7. PubMed ID: 15911249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model.
    Tsuchida K; Chaki H; Takakura T; Kotsubo H; Tanaka T; Aikawa Y; Shiozawa S; Hirono S
    J Med Chem; 2006 Jan; 49(1):80-91. PubMed ID: 16392794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and campaign synthesis of pyridine-based histone deacetylase inhibitors.
    Andrews DM; Gibson KM; Graham MA; Matusiak ZS; Roberts CA; Stokes ES; Brady MC; Chresta CM
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2525-9. PubMed ID: 18378451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ICE) inhibitors.
    Ellis CD; Oppong KA; Laufersweiler MC; O'Neil SV; Soper DL; Wang Y; Wos JA; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4728-32. PubMed ID: 16870441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors.
    Palmer JT; Rydzewski RM; Mendonca RV; Sperandio D; Spencer JR; Hirschbein BL; Lohman J; Beltman J; Nguyen M; Liu L
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3434-9. PubMed ID: 16644215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase.
    Nencka R; Votruba I; Hrebabecký H; Tloust'ová E; Horská K; Masojídková M; Holý A
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1335-7. PubMed ID: 16337119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design, synthesis, and evaluation of nanomolar type II dehydroquinase inhibitors.
    Payne RJ; Peyrot F; Kerbarh O; Abell AD; Abell C
    ChemMedChem; 2007 Jul; 2(7):1015-29. PubMed ID: 17487900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IRAK-4 inhibitors. Part 1: a series of amides.
    Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.
    Thompson LA; Liauw AY; Ramanjulu MM; Kasireddy-Polam P; Mercer SE; Maduskuie TP; Glicksman M; Roach AH; Meredith JE; Liu RQ; Combs AP; Higaki JN; Cordell B; Seiffert D; Zaczek RC; Robertson DW; Olson RE
    Bioorg Med Chem Lett; 2006 May; 16(9):2357-63. PubMed ID: 16473009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.